TrialPloS one2019

An integrated analysis of safety and tolerability of etelcalcetide in patients receiving hemodialysis with secondary hyperparathyroidism.

Geoffrey A Block et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.